BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score

BMC Clinical Pathology

Table 2 Immunohistochemistry attributes of the data set

	Negative or Not overexpressed	Low positive or Equivocal	Positive or Overexpressed
ER	0 (0.0%)	2 (1.3%)	156 (98.7%)
PR	14 (8.9%)	12 (7.6%)	132 (83.5%)
Ki-67	34 (21.5%)	46 (29.1%)	78 (49.4%)
Her2	134 (84.8%)	24 (15.2%)	0 (0%)

The relative proportions of ER, PR, Ki-67, and Her2 categories are shown as the number (and corresponding percentage) of cases

ISSN: 1472-6890